Daniel George, MD; Toni Choueiri, MD; Walter Stadler, MD; and Richard W. Joseph, MD, share insight on emerging strategies of immunotherapy in combination with VEGF TKIs and review data from IMmotion151, the phase III study of atezolizumab plus bevacizumab versus sunitinib in untreated metastatic kidney cancer.
![Python - Полный Курс по Python [15 ЧАСОВ]](https://s2.save4k.org/pic/cfJrtx-k96U/mqdefault.jpg)
